ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $13,880,000 | -50.5% | 1,000,000 | 0.0% | 0.62% | -21.4% |
Q4 2021 | $28,060,000 | -42.7% | 1,000,000 | -30.6% | 0.79% | -35.1% |
Q3 2021 | $48,946,000 | -16.8% | 1,440,000 | 0.0% | 1.22% | -18.5% |
Q2 2021 | $58,838,000 | +27.1% | 1,440,000 | +25.2% | 1.49% | +8.3% |
Q1 2021 | $46,299,000 | +9.8% | 1,150,000 | +61.3% | 1.38% | +10.4% |
Q4 2020 | $42,167,000 | +21.6% | 713,125 | 0.0% | 1.25% | -19.6% |
Q3 2020 | $34,679,000 | +0.5% | 713,125 | 0.0% | 1.55% | -23.9% |
Q2 2020 | $34,501,000 | +56.6% | 713,125 | -10.1% | 2.04% | -12.7% |
Q1 2020 | $22,033,000 | +59.0% | 793,125 | +71.3% | 2.34% | +83.6% |
Q4 2019 | $13,857,000 | -99.9% | 463,125 | 0.0% | 1.27% | -14.0% |
Q3 2019 | $14,310,562,000 | -28.8% | 463,125 | 0.0% | 1.48% | -21.3% |
Q2 2019 | $20,100,347,000 | – | 463,125 | – | 1.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
Triatomic Management LP | 121,166 | $813,024 | 0.83% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |